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Several recent studies have provided new insights into
how the infrequent B and T cells that are specific for a
particular immunizing antigen come together to form the
germinal centers that are crucial to the immune response.
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Germinal centers form in secondary lymphoid organs as a
result of immunization [1]. While they are traditionally
associated with the immune response to antigens that
require T-cell help, known as T-dependent antigens, this
connection is not absolute. The association of germinal
centers with somatic mutation of immunoglobulin variable
region genes and selection of high-affinity B cell variants
is also no longer absolute, although germinal centers
greatly enhance the efficiency with which these processes
occur. Indeed, the very existence of germinal centers is a
testament to the efficiency with which rare antigen-spe-
cific B and T lymphocytes are co-localized together with
antigen. This raises the question of how on earth these
infrequent B and T cells find each other among the
billions of irrelevant lymphocytes, all whizzing around the
lymphoid system? The answer, it appears, has much to do
with what might be called instructive migration: the
circumstances in which B and T cells are activated by
antigen dictate to a certain extent the molecules they sub-
sequently express on their surface and, as a consequence
of this, the activation and migratory signals to which they
are able to respond. 
The altered migration of B and T cells induced by
antigen has been well documented using several differ-
ent systems. Garside et al. [2], for example, used lympho-
cytes from two sets of transgenic mice, one carrying a
transgene encoding a T-cell receptor specific for a
peptide from ovalbumin (OVA) and the second carrying
transgenes encoding a B-cell receptor specific for hen
egg lysozyme (HEL). When small numbers of these
donor cells were injected into recipients, they behaved
like other naive lymphocytes: B cells entered the B-cell
areas of lymph nodes called follicles, whereas T cells
stayed outside in the T-cell-rich regions (Figure 1).
When an antigen containing both the HEL and OVA
epitopes was injected after lymphocyte transfer, the
resultant movement of the antigen-specific B and T cells
could be followed by histological analysis of the lymph
nodes draining the sites of immunization. This revealed
a quite remarkable pattern of migration (Figure 1),
showing the synchronized movements of both antigen-
specific B and T cells. 
On day 1 after immunization, the OVA-specific T cells,
still in the T-cell areas, were seen to have formed clusters
resulting from their interaction with antigen-presenting
dendritic cells in the paracortical region of the lymph
nodes [3,4]. The B cells, still scattered throughout the fol-
licles, showed reduced expression of surface immunoglob-
ulin M, indicative of an interaction with antigen. It would
therefore appear that, in this response, antigen priming of
B and T cells occurs simultaneously, but separately. By
day 2, OVA-specific T cells were found to be proliferating
and, more importantly, to have migrated to the edge of the
paracortical area, adjacent to the follicle. Thus the
antigen-specific and activated T cells were now located
adjacent to the B-cell area. 
By this time, the HEL-specific B cells, having restored
surface immunoglobulin M expression, had also migrated
to the edge of the follicle so as to abut the T-cell area.
The antigen-specific T and B cells thus co-localize at the
B-cell side of the boundary between their respective areas
in the lymph node, and in this way the consummation
necessary for T-cell-dependent antibody production
occurs. In this particular response, Garside et al. [2]
observed around 70% of OVA-specific T cells in physical
contact with HEL-specific B cells, again showing the effi-
ciency with which these two cell types find each other.
Similar analyses of the immune response in the spleen
([3,5,6] for example) showed that, in this lymphoid organ,
B cell–T cell interaction and proliferation occur in the 
T-cell areas, possibly reflecting differences in lymphocyte
migration between spleen and lymph node.
Like all meaningful relationships, that between the
antigen-specific B and T cells continues long after the first
assignation. By day 3 of the response, Garside et al. [2]
found that many of the HEL-specific B cells and OVA-spe-
cific T cells were located within the follicles, where they
continued to proliferate, resulting in histologically recogniz-
able germinal centers by about day 4. Some of the HEL-
specific B cells, however, did not return to the depths of the
follicle, but rather continued their migration on into the
medulla of the lymph node. Garside et al. [2] suggest that,
as foci of antibody-forming cells do not arise in this
response, these B cells may be on their way to the bone
marrow [2]. This may or not be the case, as it is now rela-
tively clear that bone marrow antibody-forming cells derive
primarily from the germinal center, rather than the pre-ger-
minal center period described above [7]. In responses previ-
ously monitored in the spleen, some of the antigen-specific
B cells remain in the T-cell area and do give rise to foci of
antibody-forming cells, highlighting another potential dif-
ference between these two lymphoid organs.
The rare antigen-specific B and T cells thus come
together fairly soon after exposure to immunizing antigen.
How are these lymphocytes instructed to follow the path-
ways that result in their meeting? And, of equal impor-
tance, how do they know what to do when they eventually
meet? A partial answer to these questions is provided by
the recent work of Flynn et al. [8]. They examined the
effect of co-stimulating CD4 T cells — helper T cells as
defined by expression of the T-cell coreceptor CD4 —
through the cell-surface protein OX40 [8]. 
OX40 has had an interesting, albeit brief, history. It was
originally identified as a member of the tumor necrosis
factor (TNF) receptor family, expression of which is
induced upon T-cell activation [9]. Antibodies to OX40
were found to co-stimulate activated T cells [10]. The
ligand for OX40, imaginatively called OX40-ligand
(OX40L), is upregulated on activated B cells [11] and
expressed constitutively on some dendritic cells, at least in
humans [12]. Blocking the OX40–OX40L interaction
significantly inhibits production of immunoglobulin G
antibodies during a T-cell dependent response, but does
not affect the generation of either germinal centers or
memory B cells in spleen [5]. Furthermore, OX40 is
known to be upregulated on CD4 T cells early in an
immune response, with kinetics to match the upregulation
of OX40L [5,8]. It would appear that OX40 has many of
the hallmarks of a molecule that is critical in defining the
early stages of an immune response. 
When CD4 T cells that have been primed by an initial
activating stimulus are subsequently restimulated, for
example with antibodies against the T-cell receptor
complex (anti-CD3), they secrete cytokines. Flynn et al.
[8] found that, if membrane-bound OX40L is present
when T cells are initially activated by immobilized anti-
CD3 and soluble anti-CD28 antibodies, then on restimu-
lation the cells secreted predominantly interleukin-4
(IL-4). In the absence of OX40L, interferon-γ (IFN-γ)
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Early stages of an immune response. The figure shows the distribution
of antigen-specific B and T cells in the lymphoid areas of a lymph node
at various times after exposure to an immunizing antigen, with B cells
(green) in follicles (F) and T cells (red) in the paracortex (P).
Extrafollicular dendritic cells are also shown (blue). Immunization with
antigen results in time-dependent changes in the distribution of these
cells. B and T cells show evidence of priming by day 1 post
immunization, but remain in their respective areas. By day 2, both cell
types migrate to the boundary of the B-cell and T-cell areas, and come
in physical contact. Days 2, 3 and 4 are also periods of lymphocyte
proliferation, culminating in the formation of germinal centers. Some
antigen-specific B cells differentiate into antibody-forming cells and
migrate away from the follicles. The changes in expression of
molecules important for the initiation of the immune response are
indicated. (Compiled from data in [2,6,8].)
production dominated the cytokine response. OX40L thus
biased the T-cell culture so that it took on the appearance
of a so-called Th2 population. 
Th2 cells are predisposed to stimulate humoral — that is,
antibody-based — rather than cell-mediated immunity.
That the ligation of OX40 should preferentially have this
outcome in vitro is made significant by the fact that the
interaction of activated T and B cells presumably results
in just such a stimulatory signal being delivered to the T
cells by the activated B cells. Indeed, in situ tracking of
IL-4 mRNA levels during an immune response showed
that this cytokine is expressed with very similar kinetics to
OX40 and OX40L [6]. Thus, T cell priming on an
extrafollicular dendritic cell expressing OX40L may bias
the responding population to produce Th2 cytokines.
When such T cells encounter B cells activated by the
same antigen, this bias in cytokine phenotype would pre-
sumably be reinforced, and thus enhance the differentia-
tion of B cells into antibody-forming cells.
Consideration of the relationship between stimulation of
CD4 T cells by OX40 and the development of a Th2 phe-
notype leads directly into the morass of T-cell commit-
ment. Whether the OX40–OX40L interaction induces the
differentiation of CD4 T cells into a Th2 type is not
entirely clear from the work of Flynn et al. [8]. It is apparent
that the favored outcome is an IL-4-secreting population,
and that OX40 stimulation is sufficient to counteract the
Th1 bias usually imposed by the presence of IL-12 [8]. The
bias induced through OX40 might result from the direct
induction of IL-4, a possibility favored by the authors, or it
might be due to the preferential growth of a contaminating
population already expressing IL-4. Hence the morass. 
With respect to alterations in T-cell proliferation, recent
work of Gett and Hodgkin [13] has revealed a relation-
ship between division number and cytokine production
in a population of polyclonally activated T cells. They
found that cytokine production changes in a predictable,
division-dependent manner, indicating that altering the
rate of proliferation of a T-cell culture can significantly
alter the cytokine profile secreted. While Flynn et al. [8]
did not measure the effect of OX40L on T-cell prolifera-
tion, others have noted the co-stimulatory effect of anti-
OX40 ligation on CD3-stimulated T cells [10].
Interestingly, in the experiments of Flynn et al. [8], some
IL-4 mRNA was apparent in the presumptive naive CD4
T cells stimulated by anti-CD3 plus anti-CD28 alone,
albeit much less than when OX40L was present [8]. That
is, OX40 stimulation might also amplify, rather than
induce, cytokine expression. The vexed issue of
Th1/Th2 commitment lives on.
A feature of the OX40L stimulation of CD4 T cells that is
critical for T cell–B cell interaction is the upregulation of
BLR1 (Burkitt’s lymphoma receptor-1) [8]. BLR1 is a
chemokine receptor on naive B cells necessary for the B-
cell migration into follicles in spleen and Peyer’s patches
[14]. BLR1’s ligand has been identified recently in both
humans and mice, and called B-lymphocyte chemoattrac-
tant (BLC) [15] or B-cell-attracting chemokine 1 (BCA-1)
[16]. BLC/BCA-1 is probably secreted by follicular den-
dritic cells, resulting in a gradient up which naive B cells
migrate. It may well be that CD4 T cells come under this
siren’s spell after their expression of BLR1 is upregulated
in response to stimulation through OX40, and thus
migrate towards the B-cell area. 
Activated B cells, however, move counter to the
BLC/BCA-1 gradient, out of the follicle towards the T-cell
area. Another chemokine at work? Almost certainly. Ngo et
al. [17] have cloned a chemokine expressed by dendritic
cells that is able to attract naive T cells and activated, but
not naive, B cells. Thus, the differential regulation of
chemokine receptors on activated B and T cells leads to
their positioning within the lymphoid organ, thereby
orchestrating the B cell–T cell interaction that is critical
for humoral immunity. Signaling through OX40/OX40L
not only promotes the differentiation of B and T cells into
antibody and cytokine secreting effector cells, but also
promotes the expression of a set of molecules that allows
the rare antigen-specific lymphocytes to find each other
among a sea of strangers.
It would not be science if some questions did not remain.
Among the more curious aspects of the role of OX40 is that
blocking this receptor in vivo blocks antibody production
but not germinal center formation [5]. This suggests
redundancy in the pathways capable of altering the migra-
tion of B and T cells, but a unique role for OX40L in the
differentiation of B cells into antibody-forming cells. In
mice lacking BLR1, the spleen, Peyer’s patches and
inguinal lymph nodes are seriously disrupted [14], suggest-
ing that the remaining lymph nodes may use a different
chemokine system to establish B and T cell areas. That is,
there may well be combinations of chemokines and recep-
tors, other than those described here, which are important
for the immune response in different lymphoid organs. 
Finally, the small population of antigen-specific B cells
that differentiate into antibody-forming cells and migrate
to the bone marrow represent a particularly interesting
piece of the immune response puzzle. What is it that first
induces the differentiation of these cells into antibody-
forming cells, and what is it that localizes them in the T-
cell area or directs them to the bone marrow? As these
cells are critical for protective humoral immunity, these
are very important questions.
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